GRANTS

213 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trials Not Allowed)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $4 million to fund six to 12 awards.

Due Date: December 20, 2017, and December 11, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early.

BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01) (Clinical Trials Not Allowed)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $8 million to fund three to six awards.

Due Date: December 20, 2017, and December 11, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early.

BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 - Clinical Trial Not Allowed)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: Issuing IC and partner components intend to commit an estimated total of $14 million to fund 20 awards.

Due Date: December 8, 2017, and March 15, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early.

BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $4 million to fund up to four awards.

Due Date: January 19, 2018 , by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early.

BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01)

Sponsor: National Institutes of Health

Award: The NIH BRAIN Initiative intends to commit $5.5 million in FY 2018 to fund five awards.

Due Date: December 15, 2017, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Continuation of the AMP-AD Target Discovery and Preclinical Validation Consortium (U01 Clinical Trial Optional)

Sponsor: National Institute on Aging

Award: The NIA intends to commit $10 million in FY 2018 to support up to six awards.

Due Date: February 20, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Limited Competition: Data Coordinating Center for the Accelerating Medicines Partnership Target Discovery and Preclinical Validation Consortium AMP-AD DCC (U24 Clinical Trial Not Allowed)

Sponsor: National Institute on Aging

Award: The NIA intends to commit $1.5 million in FY 2018 to fund one award.

Due Date: February 20, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this funding opportunity announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00)

Sponsor: National Institutes of Health

Award: The NIH Blueprint intends to commit $1M to fund approximately 20 awards. However, the total amount awarded and the number of awards made will depend upon the number, quality, and cost of the applications received.

Due Date: December 13, 2017, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Call for ADRC Pilot Project Proposals

Sponsor: UW Alzheimer's Disease Research Center

Award: The UW ADRC will fund at least two awards for junior researchers of up $30,000 each, and one award of up to $75,000, which is also open to established researchers new to the ADRC.

Due Date: October 16, 2017 - Letter of Intent (LOI) deadline (encouraged but not required). December 1, 2017, 11:59 p.m., full application deadline. January 15, 201818 - selection of awardees. May 1, 2018 - earliest project start Date. April 30, 2019 - latest project end date.

Heterogeneity of CNS Small Blood and Lymphatic Vessels (R01)

Sponsor: National Institutes of Health

Award: NIH Blueprint for Neuroscience Research intends to fund up to 20 awards, corresponding to a total of $ 6 million, for fiscal year 2018, for this and the related FOA (RFA-NS-18-004) "Human Studies of Target Identification, Biomarkers and Disease Mechanisms Specific to CNS Small Blood and Lymphatic Vessels". Future year amounts will depend on annual appropriations.

Due Date: December 11, 2017, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: Applicants may request up to $1,000,000 direct costs per year with the follow exception: applications containing a translational project and/or clinical component (i.e. clinical research project plus a clinical core) may request up to $1,500,000 direct costs per year.

Due Date: December 15, 2017, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

High Impact Neuroscience Research Resource Grants (R24)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: NINDS intends to commit $1,200,000 in FY 2018 to fund approximately five awards.

Due Date: February 9, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Current Filters

No filters selected

Filter By